同义名 : | Q-35 | |
CAS号 : | 127294-70-6 | |
货号 : | A105718 | |
分子式 : | C20H24FN3O4 | |
纯度 : | 98% | |
分子量 : | 389.42 | |
MDL号 : | MFCD00864925 | |
存储条件: |
粉末 Inert atmosphere,Room Temperature 液体 -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Balofloxacin is quinolone antibiotic, inhibiting the synthesis of bacterial DNA by interference with the enqyme DNA gyrase. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02302417 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | - |
NCT02641912 | Xerostomia | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02111 收起 << |
NCT00774930 | Carcinoid Syndrome | Phase 3 | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.57mL 0.51mL 0.26mL |
12.84mL 2.57mL 1.28mL |
25.68mL 5.14mL 2.57mL |
参考文献 |
---|
[1]Alksne L. Balofloxacin Choongwae. Curr Opin Investig Drugs. 2003 Feb;4(2):224-9. |